Related Experiment Video
Updated: Jul 31, 2025

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Symptom Clusters That Included Gastrointestinal Symptoms Among Children Receiving Cancer Treatments: A Scoping Review
Donruedee Kamkhoad1, Sheila Judge Santacroce1, Ratchanok Phonyiam2
1University of North Carolina at Chapel Hill.
Understanding gastrointestinal symptom clusters in pediatric cancer patients is crucial. This synthesis identified common GI and non-GI symptoms, highlighting the need for better assessment tools and targeted interventions.
Area of Science:
- Oncology
- Symptom Science
- Pediatric Care
Background:
- Gastrointestinal (GI) symptom cluster (SC) measurement and composition lack consistency, creating a knowledge gap.
- Understanding GI SCs is vital for effective symptom management in pediatric cancer patients.
Purpose of the Study:
- To synthesize existing research on GI symptom clusters.
- To identify common GI and non-GI symptoms in children undergoing cancer treatment.
- To inform future research on symptom assessment and intervention.
Main Methods:
- Systematic literature search of multiple databases (PubMed, Embase, CINAHL, Scopus, PsycINFO) through February 2022.
- Inclusion of 8 studies meeting specific criteria from 661 identified articles.
- Data extraction using a standardized form, focusing on SCs with GI symptoms and influencing factors.
Main Results:
- Identified 12 frequently reported GI and non-GI symptoms across 20 SCs.
- Calculated phi correlation coefficients to determine the strength of association between co-occurring symptoms.
- Revealed patterns of symptom co-occurrence within GI SCs.
Conclusions:
- Emphasizes the need for improved tools to comprehensively assess GI and non-GI symptoms in pediatric cancer patients.
- Recommends the development of interventions targeting shared underlying mechanisms of these symptoms.
- Highlights the importance of continued research in pediatric oncology symptom management.
More Related Videos
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists